An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study - Al-Samkari, H; Kasthuri, R S; Parambil, J G (Haematologica, 2020)
(e-pub ahead of print)